First, we found that consistent with earlier results (Figure 1, A–C), mcr84 alone slowed tumor growth in Flk-1fl/fl control animals; however, ablation of Vegfr2 on myeloid cells abrogated the efficacy of mcr84 (Supplemental Figure 6A). This evidence concerns the gene KDR and neoplasm.